Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Lyka Labs

BSE: 500259|NSE: LYKALABS|ISIN: INE933A01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 14, 16:00
57.65
-0.3 (-0.52%)
VOLUME 21,803
LIVE
NSE
Dec 14, 15:55
57.65
-0.3 (-0.52%)
VOLUME 41,959
Announcements on Lyka Labs

12th-Dec-2017 18:14Source: BSE

Lyka Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF)

8th-Dec-2017 16:48Source: BSE

Lyka Labs- Resignation of Director

we wish to inform you that Mr. Vinod Shanbhag Independent Director has resigned with effect from 7th December 2017.

24th-Nov-2017 22:06Source: BSE

Lyka Labs- Outcome of Board Meeting

The Board of Directors at their meeting held on 24th November, 2017 has considered un- audited standalone financial results for the second quarter and six months ended 30th September, 2017

20th-Nov-2017 14:51Source: BSE

Lyka Labs- Board Meeting Rescheduled

The Board meeting which was convened on November 22, 2017 is rescheduled on November 24, 2017 for consideration and taking on record unaudited standalone financial results for the second quarter and s...

16th-Nov-2017 17:26Source: BSE

Lyka Labs- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Enai Trading and Investments Pvt Ltd

14th-Nov-2017 14:15Source: BSE

Lyka Labs- Board Meeting On 22Nd November, 2017

we wish to inform you that the Board Meeting is convened on 22nd November, 2017 to consider and take on record Unaudited Standalone Financial Results for the Second Quarter and Six Months ended 30th S...

10th-Nov-2017 15:01Source: BSE

Lyka Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Enai Trading And Investment Pvt Ltd

6th-Nov-2017 12:45Source: BSE

Lyka Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF)

28th-Oct-2017 17:14Source: BSE

Lyka Labs- Compliance Certificate For The Half Year Ended 30Th September, 2017

Compliance certificate for the half year ended 30th September, 2017 duly signed by our RTA i.e. Sharex Dynamic (India) Private Limited and Compliance officer of the Company pursuant to Regulation 7(3)...

21st-Oct-2017 17:33Source: BSE

Lyka Labs- Retirement

we wish to inform you ?hat M/s M A Parikh & Co. Statutory Auditors and M/s Thacker butala Desai, Branch Auditor have retired at 38th Annual General meeting of members of the Company held on 29th Septe...

1 2 3 4 5 Next >>
Quick Links for Lyka Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.